Authors' reply: Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension (Br J Surg 2010; 97: 910-916)

2010 ◽  
Vol 97 (9) ◽  
pp. 1452-1453
Author(s):  
N. Kinjo
Keyword(s):  
Risk Factors ◽  
Portal Hypertension ◽  
Venous Thrombosis ◽  
Portal Venous Thrombosis

Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension

2010 ◽  
Vol 97 (6) ◽  
pp. 910-916 ◽  
Author(s):  
N. Kinjo ◽  
H. Kawanaka ◽  
T. Akahoshi ◽  
M. Tomikawa ◽  
N. Yamashita ◽  
...  
Keyword(s):  
Risk Factors ◽  
Portal Hypertension ◽  
Venous Thrombosis ◽  
Portal Venous Thrombosis

Su1641 Portal Venous Thrombosis After Distal Pancreatectomy: Risk Factors and Outcomes

2013 ◽  
Vol 144 (5) ◽  
pp. S-1080
Author(s):  
Ashwin S. Kamath ◽  
Michael L. Kendrick ◽  
Michael G. Sarr ◽  
David M. Nagorney ◽  
Robert McBane ◽  
...  
Keyword(s):  
Risk Factors ◽  
Venous Thrombosis ◽  
Distal Pancreatectomy ◽  
Portal Venous Thrombosis

scholarly journals Risk Factors Stratifications for Portal Venous Thrombosis (PVT)

2017 ◽  
Vol 06 (02) ◽  
Author(s):  
Yasir Al Azzawi ◽  
Yasir Al Abboodi ◽  
Matthew Fasullo ◽  
Joan Kheder
Keyword(s):  
Risk Factors ◽  
Venous Thrombosis ◽  
Portal Venous Thrombosis

Resistance to Activated Protein C and Factor V Leiden as Risk Factors for Venous Thrombosis

1995 ◽  
Vol 74 (01) ◽  
pp. 449-453 ◽  
Author(s):  
Rogier M Bertina ◽  
Pieter H Reitsma ◽  
Frits R Rosendaal ◽  
Jan P Vandenbroucke
Keyword(s):  
Risk Factors ◽  
Venous Thrombosis ◽  
Protein C ◽  
Activated Protein C ◽  
Factor V Leiden ◽  
Factor V

Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension

2015 ◽  
Vol 24 (3) ◽  
pp. 301-307 ◽  
Author(s):  
Jiannan Yao ◽  
Li Zuo ◽  
Guangyu An ◽  
Zhendong Yue ◽  
Hongwei Zhao ◽  
...  
Keyword(s):  
Risk Factors ◽  
Hepatocellular Carcinoma ◽  
Portal Hypertension ◽  
Hepatic Encephalopathy ◽  
Pressure Gradient ◽  
Transjugular Intrahepatic Portosystemic Shunt ◽  
Meld Score ◽  
Portosystemic Shunt ◽  
Portal Flow ◽  
Intrahepatic Portosystemic Shunt

Aims: This study aimed at assessing the risk factors for hepatic encephalopathy (HE) after transjugular intrahepatic portosystemic shunt (TIPS) in patients with hepatocellular carcinoma (HCC) and portal hypertension. Method: Consecutive patients (n=279) with primary HCC who underwent TIPS between January 1997 and March 2012 at a single institution were retrospectively reviewed. Patients were followed up for 2 years. Pre-TIPS, peri-TIPS and post-TIPS clinical variables were reviewed using univariate and multivariate analyses to identify risk factors for HE after TIPS. Results: The overall incidence of HE was 41% (114/279). Multivariate analysis showed an increased odds for HE in patients with: >3 treatments with transcatheter arterial chemoembolization (TACE) and/or trans-arterial embolization (TAE) (odds ratio [OR], 4.078; 95% confidence interval [95%CI], 1.748-9.515); hepatopetal portal flow (OR, 2.362; 95%CI, 1.032-5.404); high portosystemic pressure gradient (OR, 1.198; 95%CI, 1.073-1.336) and high pre-TIPS MELD score (OR, 1.693; 95%CI, 1.390-2.062). Odds for HE were increased 1.693 fold for each 1-point increase in the MELD score, and 1.198 fold for each 1-mmHg decrease in the post-TIPS portosystemic pressure gradient. Conclusion: The identification of clinical variables associated with increased odds of HE may be useful for the selection of appropriate candidates for TIPS. Results suggest that an inappropriate decrease in the portosystemic pressure gradient might be associated with HE after TIPS. In addition, >3 treatments with TACE/TAE, hepatopetal portal flow, and high MELD score were also associated with increased odds of HE after TIPS. Key words:  –  –  – .

A young man with bleeding esophageal varices

2018 ◽  
Vol 1 (1) ◽  
pp. 14-16
Author(s):  
Soonthorn Chonprasertsuk
Keyword(s):  
Risk Factors ◽  
Portal Hypertension ◽  
Liver Function ◽  
Physical Examination ◽  
Esophageal Varices ◽  
Noncirrhotic Portal Hypertension ◽  
Liver Histopathology ◽  
Bleeding Esophageal Varices

The noncirrhotic portal hypertension is an uncommon cause of bleeding esophagealvarices. This condition must be suspected in patients with preserved liver function. We reporta 25-year old man with SLE disease who presented with hematemesis. He had no historyor risk factors for an underlying liver condition. A huge splenomegaly was detectedby physical examination. The EGD found three large varices with red wale sign, whereas liverfunction tests were unremarkable. The noncirrhotic portal hypertension was diagnosedand confirmed by liver histopathology. Figure 1 แสดงผลการส่องกล้องทางเดินอาหารส่วนบนพบ F3 varices with red wale sign

Sign in / Sign up

Export Citation Format

Share Document